Interestingly, no government legislation similar to that of Europe is currently proposed in the U.S. or Canada that would require pharmaceutical packaging to have braille on it. The original concept of creating a North American standard stemmed from a braille workshop and discussions at an IADD Can-Am Chapter meeting. Some members had participated in a braille workshop at the IADD Annual Meeting in Switzerland in November 2006. It was felt that a proactive approach on the part of industry to develop and implement its own standard would be a way of reducing or even eliminating legislative intervention. This has allowed the standard to be developed in a time frame that fosters continuity, making it more of an international standard, and that ensures it will work from a practical standpoint.